(Q33395696)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657946%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

review article

1 reference

title

Investigational drugs in thrombotic thrombocytopenic purpura (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657946%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657946%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Carlo L Balduini

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657946%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

10 June 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657946%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Investigational Drugs

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657946%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657946%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657946%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

1087-1098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657946%20AND%20SRC:MED&resulttype=core&format=json

Pathophysiology of thrombotic thrombocytopenic purpura

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Thrombotic thrombocytopenic purpura: recognition and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Thrombotic microangiopathies: new insights and new challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Genetics and genetic testing in hemolytic uremic syndrome/thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Genetic defects leading to hereditary thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Thrombotic Microangiopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Prognostic value of inhibitory anti-ADAMTS13 antibodies in adult-acquired thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Survival and relapse in patients with thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

ADAMTS13 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

How I treat patients with thrombotic thrombocytopenic purpura: 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Treatment of Thrombotic Thrombocytopenic Purpura with Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Cryoprecipitate poor plasma does not improve early response in primary adult thrombotic thrombocytopenic purpura (TTP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Influence of type of exchange fluid on survival in therapeutic apheresis for thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Members of the Canadian Apheresis Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Efficacy and Safety Profile of Solvent/Detergent Plasma in the Treatment of Acute Thrombotic Thrombocytopenic Purpura: A Single-Center Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Role of methylene blue-treated or fresh-frozen plasma in the response to plasma exchange in patients with thrombotic thrombocytopenic purpura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Predictors of complications in therapeutic plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Cryosupernatant and solvent detergent fresh-frozen plasma (Octaplas) usage at a single centre in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Thrombotic thrombocytopenic purpura: yesterday, today, tomorrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Thrombotic thrombocytopenic purpura associated with ticlopidine. A review of 60 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

First-in-human evaluation of anti von Willebrand factor therapeutic aptamer ARC1779 in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Anti-von Willebrand factor aptamer ARC1779 for refractory thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Efficiency of curative and prophylactic treatment with rituximab in ADAMTS13-deficient thrombotic thrombocytopenic purpura: a study of 11 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: a report of 13 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Drug-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Adverse reactions associated with acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2011.588599

10.1517/13543784.2011.588599

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21657946%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference